Biopharma Insights
Leqembi, Donanemab and Tofersen: The End of the Journey or the First Step on the Road to Reversing Neurodegeneration?
Dr. Peter Hamley, Chief Scientific Officer at Samsara Therapeutics, explores whether developments in therapeutics for neurodegenerative diseases are truly disease modifying or addressing the symptoms of a deeper problem. Read more
16 Aug 2023
R&D revolution: A new paradigm of sourcing and landscaping for the pharma industry
Dr Robin Knight, Co-Founder & Co-CEO of IN-PART, discusses the emerging importance of outsourcing landscaping activities within the pharmaceuticals industry and the benefits of adopting an openly innovative approach that pools sources of innovation. Read more
12 Jul 2023
Enhancing Biotherapeutic Properties with Cell-Line Engineering
Neha Mishra, Ph.D, Senior Scientist Bioproduction at Revvity explores enhancing biotherapeutic properties with cell-line engineering. Read more
30 Jun 2023
Cell line development strategies fit for a new era of Bispecific Antibodies
Nicole Wakes, Senior Director Cell Line Development, and Simon Keen, Vice President Cell Line Development at Abzena, outline the strategies to overcome the challenges of developing BsAbs under increasing pressure for speed. Read more
26 Jun 2023
Science and tech combine to deliver cancer vaccine innovation
Scientific and technological innovation is accelerating the development of effective cancer vaccines, report Drs. Daina Vanags, Cori Gorman and Christian K. Schneider of Biopharma Excellence. Read more
12 Apr 2023
Leveraging RWE early is critical for emerging biopharma companies
Barbara Arone, vice president, real world solutions, IQVIA, examines the ways biotech and emerging biopharma companies can effectively apply real world evidence (RWE) early in the product lifecycle while staying within their resource limits. Read more
3 Mar 2023
Sage Therapeutics to Implement a 40% Workforce Reduction
Sage Therapeutics, Inc announced late last week plans to reorganise its business operations and pipeline priorities to support goals for long-term business growth. Read more
4 Sep 2023
IO Biotech Appoints Heidi Hunter to its Board of Directors
IO Biotech, a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on its T-win technology platform, announced the appointment of Heidi Hunter to its board of directors. Read more
11 Aug 2023
Lytix Biopharma’s Licensing Partner Verrica Pharmaceuticals Reports Interim Phase 2 Data With LTX-315
Lytix Biopharma announces that its licensing partner Verrica Pharmaceuticals Inc has reported lesion clearance data from Part 1 of an ongoing Phase 2 study of VP-315 (formerly known as LTX 315) for the treatment of basal cell carcinoma (BCC). Read more
11 Aug 2023
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
Key Considerations for Effective Apheresis Cell Collection
Miroslav Hlaučo, Apheresis Network Manager, SCTbio explores the key considerations for effective apheresis cell collection in our latest EPM Online Insight. Read more
24 Apr 2024
How You Can Ensure Your Processing Systems are Fit for Now and the Future
Matthias Mikkelsen, Fill/Finish Systems Specialist, Flexicon Liquid Filling, Watson-Marlow Fluid Technology Solutions discusses how you can design your processes to be compliant with the new Annex 1 guidelines. Read more
24 Apr 2024
Q&A: Renaissance Lakewood
In an interview with Jai McIntosh, Editor for EPM, Eric Kaneps, VP, Sales and Marketing at Renaissance Lakewood explores how innovation has been at the heart of the success of the company and the market. Read more
19 Apr 2024
Optimising Time-to-Market for Innovative Cell Therapy Trials
Didier Haguenauer, CMO, CellProthera discusses the need to optimise time-to-market for innovative cell therapies in our latest EPM Online Insight. Read more
16 Apr 2024
Mapping the Road to Seamless Scale-Up
Nandu Deorkar, Ph.D., MBA, senior vice president, research & development, biopharma production; and George Marquez, vice president, operations, Avantor, discuss advancing clinical trials manufacturing from pilot to production in our latest EPM issue. Read more
16 Apr 2024
Using Graphs in Drug Discovery to Probe Relationships
Life Sciences data expert Dr Alexander Jarasch on the learnings other R&D teams can gain from the use of graphs at the Institut de Recherches Servier for our latest EPM Online Insight. Read more
16 Apr 2024
Sponsored Content
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
4 Mar 2024
09:25
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
Sponsored Content
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
4 Mar 2024
09:25